» Articles » PMID: 24742975

Chronic Kidney Disease As a Risk Factor for Acute Community-acquired Infections in High-income Countries: a Systematic Review

Overview
Journal BMJ Open
Specialty General Medicine
Date 2014 Apr 19
PMID 24742975
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: A systematic review of the association of predialysis chronic kidney disease (CKD) with the incidence of acute, community-acquired infections.

Design: We searched the MEDLINE, EMBASE and Cochrane databases (inception to 16 January 2014) for studies analysing the association of predialysis kidney disease with the incidence of acute, community-acquired urinary tract infection (UTI), lower respiratory tract or central nervous system infections or sepsis. Studies were required to include at least 30 participants with and without kidney disease.

Setting And Participants: Community-based populations of adults in high-income countries.

Outcome Measures: Acute, community-acquired UTI, lower respiratory tract or central nervous system infections or sepsis.

Results: We identified 14 eligible studies. Estimates from two studies lacked 95% CIs and SEs. The remaining 12 studies yielded 17 independent effect estimates. Only three studies included infections managed in the community. Quality assessment revealed that probable misclassification of kidney disease status and poor adjustment for confounding were common. There was evidence from a few large high-quality studies of a graded association between predialysis CKD stage and hospitalisation for infection. One study found an interaction with age, with a declining effect of CKD on infection risk as age increased. There was evidence of between-studies heterogeneity (I(2)=96.5%, p<0.001) which persisted in subgroup analysis, and thus meta-analysis was not performed.

Conclusions: Predialysis kidney disease appears to be associated with increased risk of severe infection. Whether predialysis kidney disease increases the susceptibility to infections and whether age modifies this association remains unclear.

Citing Articles

Kidney Function Decline After COVID-19 Infection.

Mahalingasivam V, Faucon A, Sjolander A, Bosi A, Gonzalez-Ortiz A, Lando S JAMA Netw Open. 2024; 7(12):e2450014.

PMID: 39724377 PMC: 11672154. DOI: 10.1001/jamanetworkopen.2024.50014.


The Joint Effect of Renal Function Status and Coagulation Biomarkers on In-Hospital Outcomes in Acute Ischemic Stroke Patients With Intravenous Thrombolysis.

Lu M, Xue J, Wang Y, Chen D, Cao Y, Zhong C Immun Inflamm Dis. 2024; 12(12):e70099.

PMID: 39660934 PMC: 11633047. DOI: 10.1002/iid3.70099.


Lower prognostic nutritional index is associated with a greater decline in long-term kidney function in general population.

Park I, Ko N, Jin M, Lee Y Nutr J. 2024; 23(1):146.

PMID: 39567944 PMC: 11580526. DOI: 10.1186/s12937-024-01047-8.


Drugs with a negative impact on cognitive functions (part 3): antibacterial agents in patients with chronic kidney disease.

Liabeuf S, Hafez G, Pesic V, Spasovski G, Bobot M, Maciulaitis R Clin Kidney J. 2024; 17(8):sfae174.

PMID: 39114495 PMC: 11304602. DOI: 10.1093/ckj/sfae174.


Chronic kidney disease and the global public health agenda: an international consensus.

Francis A, Harhay M, Ong A, Tummalapalli S, Ortiz A, Fogo A Nat Rev Nephrol. 2024; 20(7):473-485.

PMID: 38570631 DOI: 10.1038/s41581-024-00820-6.


References
1.
Dalrymple L, Go A . Epidemiology of acute infections among patients with chronic kidney disease. Clin J Am Soc Nephrol. 2008; 3(5):1487-93. PMC: 4571152. DOI: 10.2215/CJN.01290308. View

2.
Watt J, OBrien K, Benin A, McCoy S, Donaldson C, Reid R . Risk factors for invasive pneumococcal disease among Navajo adults. Am J Epidemiol. 2007; 166(9):1080-7. DOI: 10.1093/aje/kwm178. View

3.
Sarnak M, Jaber B . Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000; 58(4):1758-64. DOI: 10.1111/j.1523-1755.2000.00337.x. View

4.
Hackam D, Mamdani M, Li P, Redelmeier D . Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet. 2006; 367(9508):413-8. DOI: 10.1016/S0140-6736(06)68041-0. View

5.
Kausz A, Gilbertson D . Overview of vaccination in chronic kidney disease. Adv Chronic Kidney Dis. 2006; 13(3):209-14. DOI: 10.1053/j.ackd.2006.04.007. View